Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN Synergy Pharmaceuticals Inc.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Associate Professor Sandra Langeslag kicks off UMSL Lecture Series at City Foundry
Langeslag discussed her research on the neurocognition of romantic love to open the new series.
MORE IN Synergy Pharmaceuticals Inc.
LATEST NEWS
- Associate Professor Sandra Langeslag kicks off UMSL Lecture Series at City Foundry
- Honors College welcomes 2025 cohort of five Opportunity Scholars and 20 St. Louis Scholars
- Joint Engineering grad Emmanuel Morgan lands project management role at Nooter/Eriksen
- Nursing, Optometry students team up for mock hypertension exams in Nursing Simulation Lab
- Tanner Reichl and Thanh Ly to study abroad with support of Gilman International Scholarship
- Political science and public policy graduate Ally Davis continuing studies in Accelerated Master’s Program while eyeing law school
- International Business grad Max Hood learned to ‘lean in’ to UMSL opportunities
- Eye on UMSL: Tornado Response Drive
- Explore Germany with UMSL alum Franziska Hauptmann
- Education alum Alexis Perez Lane serves as public policy fellow on Capitol Hill
